Bezuclastinib Tablets (Formulation A)

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in SSM

Drug Information

Target Indication

SSM

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

COGT

Cogent Biosciences, Inc.

Related Pipeline

Advanced Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

Advanced Systemic Mastocytosis (AdvSM)

Intrahepatic Cholangiocarcinoma (Icc)

Gastrointestinal Stromal Tumors

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts